We found a significant increase in p-Tau staining intensity in the dentate of the mice injected with DS-AD NDEVs, compared to the controls (see Figure 4), and this staining was even more prominent 4 months post-injection in DS-AD vs. Control NDEVs-injected WT mice. This evidence concerns the gene MAPT and Dravet syndrome.